FAQs

Answers to frequently asked
questions about TRIUMEQ

What is TRIUMEQ?

TRIUMEQ is a prescription HIV-1 (Human Immunodeficiency Virus type 1) medicine used alone or with other antiretroviral medicines to treat HIV-1 infection. HIV-1 is the virus that causes Acquired Immune Deficiency Syndrome (AIDS). TRIUMEQ contains 3 prescription medicines, abacavir (ZIAGEN), dolutegravir (TIVICAY), and lamivudine (EPIVIR®).

  • TRIUMEQ is not for use by itself in people who have or have had resistance to abacavir, dolutegravir, or lamivudine.

TRIUMEQ should not be used in children.

When used alone or with other antiretroviral medicines to treat HIV-1 infection, TRIUMEQ may help:

  • reduce the amount of HIV-1 in your blood. This is called “viral load.”
  • increase the number of CD4+ T-cells in your blood, which help fight off other infections.
  • Reducing the amount of HIV-1 and increasing the CD4+ (T) cells in your blood may help improve your immune system. This may reduce your risk of death or getting infections that can happen when your immune system is weak (opportunistic infections).

TRIUMEQ does not cure HIV-1 infection or AIDS. You must keep taking HIV-1 medicines to control HIV-1 infection and decrease HIV-related illnesses.

Avoid doing things that can spread HIV-1 infection to others.

  • Do not share or re-use needles or other injection equipment.
  • Do not share personal items that can have blood or body fluids on them, like toothbrushes and razor blades.
  • Do not have any kind of sex without protection. Always practice safer sex by using a latex or polyurethane condom to lower the chance of sexual contact with any body fluids such as semen, vaginal secretions, or blood.

Ask your healthcare provider if you have any questions about how to prevent passing HIV to other people.

How should I take TRIUMEQ?

  • Take TRIUMEQ exactly as your healthcare provider tells you.
  • Do not change your dose or stop taking TRIUMEQ without talking with your healthcare provider. If you miss a dose of TRIUMEQ, take it as soon as you remember. Do not take 2 doses at the same time. If you are not sure about your dosing, call your healthcare provider.
  • Stay under the care of a healthcare provider while taking TRIUMEQ.
  • TRIUMEQ may be taken with or without food.
  • Do not run out of TRIUMEQ. The virus in your blood may increase and the virus may become harder to treat. When your supply starts to run low, get more from your healthcare provider or pharmacy.
  • If you take too much TRIUMEQ, call your healthcare provider or go to the nearest hospital emergency room right away.

What are the possible side effects of TRIUMEQ?

Click here to learn the possible
side effects of TRIUMEQ.

How should I store TRIUMEQ?

  • Store TRIUMEQ at room temperature between 68°F and 77°F (20°C and 25°C).
  • Store TRIUMEQ in the original bottle.
  • Keep the bottle of TRIUMEQ tightly closed and protected from moisture.
  • The bottle of TRIUMEQ contains a desiccant packet to help keep your medicine dry (protect it from moisture). Keep the desiccant packet in the bottle. Do not remove the desiccant packet.

Keep TRIUMEQ and all medicines out of the reach of children.

Is there other general information I should know about TRIUMEQ?

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use TRIUMEQ for a condition for which it was not prescribed. Do not give TRIUMEQ to other people, even if they have the same symptoms that you have. It may harm them.

If you would like more information, talk with your healthcare provider. You can ask your healthcare provider or pharmacist for information about TRIUMEQ that is written for health professionals.

For more information, go to www.TRIUMEQ.com or call 1-877-844-8872.

What are the ingredients in TRIUMEQ?

Active ingredients: abacavir, dolutegravir, and lamivudine.

Inactive ingredients: D-mannitol, magnesium stearate, microcrystalline cellulose, povidone, and sodium starch glycolate.

Tablet film-coating contains: iron oxide black, iron oxide red, macrogol/PEG, polyvinyl alcohol–part hydrolyzed, talc, and titanium oxide.